Your browser doesn't support javascript.
loading
Risk factors for second primary melanoma among Dutch patients with melanoma.
Schuurman, M S; de Waal, A C; Thijs, E J M; van Rossum, M M; Kiemeney, L A L M; Aben, K K H.
Affiliation
  • Schuurman MS; Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, the Netherlands.
  • de Waal AC; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Thijs EJM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van Rossum MM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Kiemeney LALM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Aben KKH; Department of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
Br J Dermatol ; 176(4): 971-978, 2017 Apr.
Article in En | MEDLINE | ID: mdl-27596937
ABSTRACT

BACKGROUND:

Patients with melanoma are at increased risk of developing subsequent primary melanomas. Knowledge about risk factors for these subsequent primaries is scarce. More evidence may help clinicians in tailoring surveillance schedules by selecting patients who could benefit from intensified surveillance.

OBJECTIVES:

To identify risk factors for a second primary cutaneous melanoma.

METHODS:

Possible risk factors for a second primary melanoma were assessed in 1127 patients with cutaneous melanoma who were diagnosed between 2003 and 2011 and completed a baseline questionnaire. Additional data were extracted from the Netherlands Cancer Registry and medical files.

RESULTS:

Fifty-three patients were diagnosed with a second melanoma during a median follow-up time of 6·3 years. The 5-year cumulative risk was 3·7% and the conditional cumulative risk was 4·6% in years 5-10 after diagnosis. In multivariable analyses, the risk of a second melanoma increased with older age at diagnosis [hazard ratio (HR) 1·03 per year; 95% confidence interval (CI) 1·00-1·06], a high naevus density (HR 7·16, 95% CI 2·89-17·75) and working outside for > 10 years (HR 2·88, 95% CI 1·38-6·03). Patients with invasive melanoma (> 1 mm) had a decreased risk compared with patients with melanoma in situ (HR 0·35, 95% CI 0·13-0·93).

CONCLUSIONS:

Besides phenotypic characteristics, cumulative sun exposure seemed to increase the risk of a second melanoma. Patients with melanoma in situ may need to be offered follow-up, which is currently not advised. As the risk of a second melanoma did not decline in years 5-10 after diagnosis, a subgroup of patients may need a longer follow-up than is currently advised.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Neoplasms, Second Primary / Melanoma Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Br J Dermatol Year: 2017 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Neoplasms, Second Primary / Melanoma Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Br J Dermatol Year: 2017 Document type: Article Affiliation country: Netherlands